These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 28731243

  • 21. Use of biologic agents in pediatric psoriasis.
    Marji JS, Marcus R, Moennich J, Mackay-Wiggan J.
    J Drugs Dermatol; 2010 Aug; 9(8):975-86. PubMed ID: 20684148
    [Abstract] [Full Text] [Related]

  • 22. Long-term efficacy of biologics in the treatment of psoriasis: what do we really know?
    Alwawi EA, Krulig E, Gordon KB.
    Dermatol Ther; 2009 Aug; 22(5):431-40. PubMed ID: 19845720
    [Abstract] [Full Text] [Related]

  • 23. Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials.
    Reich K, Burden AD, Eaton JN, Hawkins NS.
    Br J Dermatol; 2012 Jan; 166(1):179-88. PubMed ID: 21910698
    [Abstract] [Full Text] [Related]

  • 24. Biologics in dermatology: What does the future hold?
    Yavuz C.
    Dermatol Ther; 2019 Jul; 32(4):e12932. PubMed ID: 30977240
    [Abstract] [Full Text] [Related]

  • 25. Combining biologic therapies with other systemic treatments in psoriasis: evidence-based, best-practice recommendations from the Medical Board of the National Psoriasis Foundation.
    Armstrong AW, Bagel J, Van Voorhees AS, Robertson AD, Yamauchi PS.
    JAMA Dermatol; 2015 Apr; 151(4):432-8. PubMed ID: 25517130
    [Abstract] [Full Text] [Related]

  • 26. Psoriasis management in actual clinical practice: a 6-year retrospective study of 845 patients.
    Incel Uysal P, Sahin B, Yalcin B, Alkan A, Yuksel S.
    J Dermatolog Treat; 2018 Dec; 29(8):797-801. PubMed ID: 29678120
    [Abstract] [Full Text] [Related]

  • 27. Effectiveness of sequential use of biologics in the treatment of moderate to severe psoriasis in real world Canadian academic clinical practice: A cohort study.
    Qiang JK, Shahbaz A, Kim W, Marinas J, Greaves S, Yeung J.
    J Am Acad Dermatol; 2016 Jan; 74(1):176-7. PubMed ID: 26702799
    [No Abstract] [Full Text] [Related]

  • 28. Biologicals in the treatment of psoriasis.
    Boker A, Kimball AB, Rolz-Cruz G.
    Curr Opin Investig Drugs; 2007 Nov; 8(11):939-46. PubMed ID: 17979028
    [Abstract] [Full Text] [Related]

  • 29. Psoriasis Trends and Practice Gaps.
    Gottlieb AB, Greb JE, Goldminz AM.
    Dermatol Clin; 2016 Jul; 34(3):235-42. PubMed ID: 27363878
    [Abstract] [Full Text] [Related]

  • 30. The management of moderate-to-severe chronic plaque psoriasis.
    Tonini A, Panduri S, D' Erme AM, Papadia F, Romanelli M, Krueger JG, Chiricozzi A.
    G Ital Dermatol Venereol; 2017 Oct; 152(5):447-457. PubMed ID: 28534602
    [Abstract] [Full Text] [Related]

  • 31. Expert consensus on the persistence of biological treatments in moderate-to-severe psoriasis.
    de la Cueva Dobao P, Notario J, Ferrándiz C, López Estebaranz JL, Alarcón I, Sulleiro S, Borrás J, Daudén E, Carrascosa JM, Sánchez Carazo JL, Monte Boquet E, Puig L.
    J Eur Acad Dermatol Venereol; 2019 Jul; 33(7):1214-1223. PubMed ID: 31037770
    [Abstract] [Full Text] [Related]

  • 32. Identifying the biologic closest to the ideal to treat chronic plaque psoriasis in different clinical scenarios: using a pilot multi-attribute decision model as a decision-support aid.
    Guibal F, Iversen L, Puig L, Strohal R, Williams P.
    Curr Med Res Opin; 2009 Dec; 25(12):2835-43. PubMed ID: 19916728
    [Abstract] [Full Text] [Related]

  • 33. Satisfaction of treatment with biologics is high in psoriasis: results from the Bio-CAPTURE network.
    van den Reek JM, van Lüumig PP, Otero ME, Zweegers J, van de Kerkhof PC, Ossenkoppele PM, Njoo MD, Mommers JM, Koetsier MI, Arnold WP, Sybrandy-Fleuren BA, Kuijpers AL, Andriessen MP, Seyger MM, Kievit W, de Jong EM.
    Br J Dermatol; 2014 May; 170(5):1158-65. PubMed ID: 24484403
    [Abstract] [Full Text] [Related]

  • 34. Switching of biologics in psoriasis: Reasons and results.
    Honda H, Umezawa Y, Kikuchi S, Yanaba K, Fukuchi O, Ito T, Nobeyama Y, Asahina A, Nakagawa H.
    J Dermatol; 2017 Sep; 44(9):1015-1019. PubMed ID: 28488283
    [Abstract] [Full Text] [Related]

  • 35. Structural Insights: What Makes Some IL-23 Biologics More Effective in Psoriasis.
    Daniele SG, Galimberti F, Bunick CG.
    J Drugs Dermatol; 2024 Oct 01; 23(10):903-904. PubMed ID: 39361690
    [No Abstract] [Full Text] [Related]

  • 36. Biologic therapy with or without topical treatment in psoriasis: what does the current evidence say?
    Jensen JD, Delcambre MR, Nguyen G, Sami N.
    Am J Clin Dermatol; 2014 Oct 01; 15(5):379-85. PubMed ID: 25027461
    [Abstract] [Full Text] [Related]

  • 37. Satisfaction with current psoriasis treatment: misalignment between physician and patient perceptions.
    Korman NJ, Zhao Y, Pike J, Roberts J, Sullivan E, Kemhus M.
    Dermatol Online J; 2016 Jul 15; 22(7):. PubMed ID: 27617714
    [Abstract] [Full Text] [Related]

  • 38. Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey.
    van de Kerkhof PC, Reich K, Kavanaugh A, Bachelez H, Barker J, Girolomoni G, Langley RG, Paul CF, Puig L, Lebwohl MG.
    J Eur Acad Dermatol Venereol; 2015 Oct 15; 29(10):2002-10. PubMed ID: 25885420
    [Abstract] [Full Text] [Related]

  • 39. Biologic and Conventional Systemic Therapies Show Similar Safety and Efficacy in Elderly and Adult Patients With Moderate to Severe Psoriasis.
    Garber C, Plotnikova N, Au SC, Sorensen EP, Gottlieb A.
    J Drugs Dermatol; 2015 Aug 15; 14(8):846-52. PubMed ID: 26267729
    [Abstract] [Full Text] [Related]

  • 40. Racial differences in access to psoriasis biologics.
    Parraga SP, Fleischer AB, Feldman SR.
    J Dermatolog Treat; 2024 Dec 15; 35(1):2360572. PubMed ID: 38852941
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.